<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02523339</url>
  </required_header>
  <id_info>
    <org_study_id>UI-CRVO-2015</org_study_id>
    <nct_id>NCT02523339</nct_id>
  </id_info>
  <brief_title>Study of Retinal Oxygenation in Central Retinal Vein Occlusion</brief_title>
  <official_title>Multicenter Study of Retinal Oxygenation in Central Retinal Vein Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iceland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Jena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinical Research Center Memorial A. de Rothschild</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Palacky University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Toyama</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iceland</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to test if oxygen saturation in retinal vessels is correlated
      with clinical parameters, such as visual acuity, central retinal thickness and presence of
      neovascularization. Retinal oximetry is performed with fundus camera based oximeters. The
      study will not entail change in treatment of the disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retinal vessel oxygen saturation</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Central retinal thickness</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence or absence of ocular neovascularisation</measure>
    <time_frame>12 months</time_frame>
    <description>As determined by gonioscopic examination</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retinal vessel oxygen saturation</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central retinal thickness</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence or absence of ocular neovascularisation</measure>
    <time_frame>Baseline</time_frame>
    <description>As determined by gonioscopic examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal vessel oxygen saturation</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central retinal thickness</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence or absence of ocular neovascularisation</measure>
    <time_frame>3 months</time_frame>
    <description>As determined by gonioscopic examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal vessel oxygen saturation</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central retinal thickness</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence or absence of ocular neovascularisation</measure>
    <time_frame>6 months</time_frame>
    <description>As determined by gonioscopic examination</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Retinal Vein Occlusion</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspected central retinal vein occlusion (CRVO) will be invited to
        participate.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspected central retinal vein occlusion.

          -  Informed consent for participation.

          -  No treatment before the first oximetry measurement.

        Exclusion Criteria:

          -  History of other retinal disease. Glaucoma and diabetes without retinopathy are not
             exclusion criteria but should be registered.

          -  History of cardiovascular or respiratory diseases that can be expected to influence
             systemic or retinal oxygen saturation. Examples: Known COPD or carotid stenosis.
             Subjects with high blood pressure will not be excluded but blood pressure should be
             registered.

          -  Poor quality images will be excluded based on the images themselves. Therefore,
             grading of cataract or other media opacities is not strictly necessary for the purpose
             of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sveinn H. Hardarson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iceland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sveinn H. Hardarson, PhD</last_name>
    <phone>+354 8490347</phone>
    <email>sveinnha@hi.is</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Einar Stefansson, MD / PhD</last_name>
    <phone>+354 5437217</phone>
    <email>einarste@landspitali.is</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Clinical Pharmacology, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Garhofer, MD, Assoc. Prof. PD</last_name>
      <phone>+43 1 40400 29810</phone>
      <email>gerhard.garhoefer@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Doreen Schmidl, MD, PhD</last_name>
      <phone>+43 1 40400 29810</phone>
      <email>doreen.schmidl@meduniwien.ac.at</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Department of Ophthalmology, University Hospital and Faculty of Medicine and Dentistry, Palacky University Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>77900</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Sin, MD, PhD</last_name>
      <phone>+420 603797358</phone>
      <email>sin.martin@seznam.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aarhus University. Department of Clinical Medicine - The Department of Ophthalmology</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toke Bek, MD / PhD</last_name>
      <phone>0045 78463223</phone>
      <email>toke.bek@mail.tele.dk</email>
    </contact>
    <contact_backup>
      <last_name>Sidse Kringelholt, MD</last_name>
      <email>sidse.kringelholt@clin.au.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brunhilde Seidel-Kwem, PhD</last_name>
      <phone>+49-3641-933195</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Iceland / Landspitali, Dept. of Ophthalmology</name>
      <address>
        <city>Reykjavik</city>
        <zip>101</zip>
        <country>Iceland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sveinn H Hardarson, PhD</last_name>
      <phone>+354 8490347</phone>
      <email>sveinnha@hi.is</email>
    </contact>
    <contact_backup>
      <last_name>Einar Stefansson, MD / PhD</last_name>
      <phone>+354 5437217</phone>
      <email>einarste@landspitali.is</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Eye Clinic of the University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>Basel-Stadt</state>
        <zip>4055</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Konstantin Gugleta, MD</last_name>
      <phone>+41 61 265 8756</phone>
      <email>Konstantin.Gugleta@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Selim Orgül, MD</last_name>
      <phone>+41 265 8633</phone>
      <email>Selim.Orguel@usb.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinical Research Center Memorial A. de Rothschild</name>
      <address>
        <city>Geneva</city>
        <zip>1208</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gordana Sunaric Mégevand, MD</last_name>
      <phone>+41 79 478 59 38</phone>
      <email>g.su.meg@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Sylvain Roy, MD/Phd</last_name>
      <phone>+41 79 44 55 130</phone>
      <email>sylvain.roy@epfl.ch</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Aston University School of Life and Health Sciences</name>
      <address>
        <city>Birmingham</city>
        <zip>B4 7ET</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rebekka Heitmar, PhD</last_name>
      <phone>0044 121 204 3853</phone>
      <email>R.Heitmar1@aston.ac.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Iceland</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2015</study_first_submitted>
  <study_first_submitted_qc>August 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iceland</investigator_affiliation>
    <investigator_full_name>Sveinn Hakon Hardarson</investigator_full_name>
    <investigator_title>Post-doctoral researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Vein Occlusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

